LPAR3 and breast carcinoma: The elevated expressions of Lysophosphatidic Acid Receptor 1 and 3 (LPAR1 and LPAR3), two other hub genes in module 2, are associated with poorly differentiated and advanced stages of breast cancer [63,64].